07.01.15
SpineGuard received regulatory clearance to market its Classic PediGuard products in China.
“This regulatory clearance is the result of a diligent collaborative process with General Care International (SpineGuard’s distributor in China),” said Pierre Jérôme, co-founder and CEO of SpineGuard. “It is a major milestone for SpineGuard and further validates the value of our DSG (Dynamic Surgical Guidance)-based PediGuard device for making spine surgery safer.”
The China spine market has become the second-largest market in spine after the United States, according to figures cited by the company, and is projected to be worth more than $1 billion by 2019 according to iData Research, driven by an aging population, increasing disease, improving treatment rate and growing affordability.
“The number of spine fusions is growing rapidly across China, and I believe there is a strong need for a simple smart device like PediGuard consistently ensuring safe and accurate placement of pedicle screws,” added Professor Yong Qiu, chief spinal surgeon at the Nanjing University Hospital.
SpineGuard was founded in 2009 in Paris, France. The company’s Dynamic Surgical Guidance technology is used in the firm’s primary product, the PediGuard— a handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Nearly 40,000 surgical procedures have been performed worldwide with PediGuard, the company claims. In addition to Paris, SpineGuard has offices in San Francisco, Calif.
“This regulatory clearance is the result of a diligent collaborative process with General Care International (SpineGuard’s distributor in China),” said Pierre Jérôme, co-founder and CEO of SpineGuard. “It is a major milestone for SpineGuard and further validates the value of our DSG (Dynamic Surgical Guidance)-based PediGuard device for making spine surgery safer.”
The China spine market has become the second-largest market in spine after the United States, according to figures cited by the company, and is projected to be worth more than $1 billion by 2019 according to iData Research, driven by an aging population, increasing disease, improving treatment rate and growing affordability.
“The number of spine fusions is growing rapidly across China, and I believe there is a strong need for a simple smart device like PediGuard consistently ensuring safe and accurate placement of pedicle screws,” added Professor Yong Qiu, chief spinal surgeon at the Nanjing University Hospital.
SpineGuard was founded in 2009 in Paris, France. The company’s Dynamic Surgical Guidance technology is used in the firm’s primary product, the PediGuard— a handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Nearly 40,000 surgical procedures have been performed worldwide with PediGuard, the company claims. In addition to Paris, SpineGuard has offices in San Francisco, Calif.